List of English Research Publications (Google Scholar) https://goo.gl/RySoj2
Research Overview
My work has consistently focused on elucidating the close relationship between chronic inflammation, a central theme of modern ophthalmology, and pathological angiogenesis (abnormal blood vessel growth), a leading cause of blindness. Starting from clinical experience at Kyushu University, it continued with basic immunology at the Medical Institute of Bioregulation and further training at Harvard University in the United States. In this way I have practiced ideal “translational research,” applying challenges from clinical practice to basic research and returning the results to the clinic.
The core of my research is the concept of the “inflammation–angiogenesis link”: the idea that the inflammatory response in the eye is not merely a tissue defense reaction but a central mechanism that actively drives the pathological angiogenesis seen in age-related macular degeneration, diabetic retinopathy, and other diseases. Based on this view, I have worked out the molecular mechanisms common to a wide range of eye diseases, from inflammatory diseases such as uveitis to neovascular diseases, and have reported several important findings that may lead to new treatments.
List of Research Papers
Comprehensive Analysis of Inflammatory Mediators in Vitreoretinal Diseases
- Comprehensive Analysis of Inflammatory Immune Mediators in Vitreoretinal Diseases
- Yoshimura, T., Sonoda, K.H., Sugahara, M., Mochizuki, Y., Enaida, H., Oshima, Y., Ueno, A., Hata, Y., Yoshida, H. and Ishibashi, T. (2009) ‘Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases’, PLoS One, 4(12), p. e8158.
- Commentary: We analyzed, on a large scale, the intraocular fluid of 345 patients who underwent surgery for various retinal diseases, including diabetic retinopathy, retinal vein occlusion, and retinal detachment. We found that, regardless of the type of disease, three major inflammatory substances (IL-6, IL-8, and MCP-1) were commonly elevated in almost all patients.
- First Author: I conducted a large-scale analysis of the intraocular fluid from 345 patients with various retinal diseases, such as diabetic retinopathy and retinal vein occlusion. I discovered three major inflammatory substances (IL-6, IL-8, and MCP-1) that were commonly elevated across almost all patients, regardless of their specific disease.
Basic Immunology and Signal Transduction
- Two-Sided Roles of IL-27: Induction of Th1 Differentiation on Naive CD4+ T Cells versus Suppression of Proinflammatory Cytokine Production…
- Yoshimura, T., Takeda, A., Hamano, S., Miyazaki, Y., Kinjyo, I., Ishibashi, T., Yoshimura, A. and Yoshida, H. (2006) ‘Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production…’, Journal of Immunology, 177(8), pp. 5377–5385.
- Commentary: We found that IL-27, an immunoregulatory substance, has both an “accelerator” and a “brake.” It acts as an accelerator that promotes the response in immature cells at an early stage of the immune response, and as a brake that suppresses excessive responses in fully activated cells. We clarified this finely tuned balancing mechanism.
- First Author: I discovered that the immune-regulating substance IL-27 has both “accelerator” and “brake” functions. I clarified the sophisticated balancing mechanism where it acts as an accelerator for immature cells in the early stages of an immune response, but as a brake to suppress excessive reactions in fully activated cells.
- Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1
- Kinjyo, I., Inoue, H., Hamano, S., Fukuyama, S., Yoshimura, T., Koga, K., Takaesu, G., Yoshimura, T., Kobayashi, T. and Yoshimura, A. (2006) ‘Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1’, Journal of Experimental Medicine, 203(4), pp. 1021–1031.
- Commentary: Some immune cells have a “brake” called SOCS3 that stops the signals of cytokines, the messenger molecules of the immune system. When we examined cells lacking this brake, we found an unexpected phenomenon: they instead produced large amounts of other substances that suppress immune responses (IL-10 and TGF-β1).
- Collaborative study with Drs. Kinjyo and Yoshimura.
- Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor α (WSX-1)
- Sugiyama, N., Nakashima, H., Yoshimura, T., Sadanaga, A., Shimizu, S., … and Yoshida, H. (2008) ‘Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor α (WSX-1)’, Annals of the Rheumatic Diseases, 67(10), pp. 1461–1467.
https://pmc.ncbi.nlm.nih.gov/articles/PMC2566534/ - Commentary: Using a mouse model that shows a condition similar to systemic lupus erythematosus (SLE), we found that overexpressing the IL-27 receptor (WSX-1) improves the disease. This research suggests the possibility of artificially strengthening IL-27 signaling as a new treatment for autoimmune diseases, which are intractable.
- Collaborative study with Drs. Sugiyama, Nakajima, and Yoshida.
- Sugiyama, N., Nakashima, H., Yoshimura, T., Sadanaga, A., Shimizu, S., … and Yoshida, H. (2008) ‘Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor α (WSX-1)’, Annals of the Rheumatic Diseases, 67(10), pp. 1461–1467.
- WSX-1 over-expression in CD4+ T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation
- Takeda, A., Hamano, S., Shiraishi, H., Yoshimura, T., Ogata, H., … and Yoshida, H. (2005) ‘WSX-1 over-expression in CD4+ T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation’, International Immunology, 17(7), pp. 889–897.
https://doi.org/10.1093/intimm/dxh268 - Commentary: We showed that overexpressing the IL-27 receptor (WSX-1) in CD4+ T cells, a type of immune cell, causes the cells to proliferate abnormally and to produce excessive cytokines. This indicates that WSX-1 plays an important role in strongly activating immune responses.
- Collaborative study with Drs. Takeda and Yoshida.
- Takeda, A., Hamano, S., Shiraishi, H., Yoshimura, T., Ogata, H., … and Yoshida, H. (2005) ‘WSX-1 over-expression in CD4+ T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation’, International Immunology, 17(7), pp. 889–897.
- Sjögren’s Syndrome-Like Ocular Surface Disease in Thrombospondin-1 Deficient Mice
- Turpie, B., Yoshimura, T., Gulati, A., Ghafoori, P. and Masli, S. (2009) ‘Sjögren’s syndrome-like ocular surface disease in thrombospondin-1 deficient mice’, American Journal of Pathology, 175(3), pp. 1136–1147.
https://pmc.ncbi.nlm.nih.gov/articles/PMC2731132/ - Commentary: Using an animal model of Sjögren’s syndrome, known for dry eye, we studied the role of a protein called thrombospondin-1, which is important for maintaining immune balance in the body. We found that when this protein is deficient, an autoimmune reaction occurs in the lacrimal gland and severe dry eye develops spontaneously.
- Collaborative study with Drs. Turpie and Masli.
- Turpie, B., Yoshimura, T., Gulati, A., Ghafoori, P. and Masli, S. (2009) ‘Sjögren’s syndrome-like ocular surface disease in thrombospondin-1 deficient mice’, American Journal of Pathology, 175(3), pp. 1136–1147.
Molecular Mechanisms and Treatment Strategies for Autoimmune Uveitis
- Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis
- Yoshimura, T., Sonoda, K.H., Ohguro, N., Ohsugi, Y., Ishibashi, T., Cua, D.J., Kobayashi, T., Yoshida, H. and Yoshimura, A. (2009) ‘Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis’, Rheumatology (Oxford), 48(4), pp. 347–354.
https://pmc.ncbi.nlm.nih.gov/articles/PMC2722800/ - Commentary: We found that IL-6, an inflammatory substance, is markedly increased inside the eyes of patients with intractable uveitis. IL-6 is deeply involved in the activation of Th17 cells, the principal immune cells that cause uveitis. Using an animal model, we demonstrated that blocking IL-6 strongly suppresses the activity of Th17 cells and dramatically improves uveitis. This research opened the way to the development of new treatments for uveitis and became one of the important scientific bases leading to current drugs for intractable diseases such as tocilizumab (Actemra®).
- First Author: I found a marked increase of the inflammatory substance IL-6 inside the eyes of patients with intractable uveitis. This IL-6 is deeply involved in activating Th17 cells, the main culprits behind uveitis. Using animal models, we proved that blocking IL-6 therapy powerfully suppresses Th17 cell function, dramatically improving uveitis. This research paved the way for developing new treatments for uveitis and provided crucial scientific evidence that led to current treatments for refractory diseases like Actemra (tocilizumab).
- Yoshimura, T., Sonoda, K.H., Ohguro, N., Ohsugi, Y., Ishibashi, T., Cua, D.J., Kobayashi, T., Yoshida, H. and Yoshimura, A. (2009) ‘Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis’, Rheumatology (Oxford), 48(4), pp. 347–354.
- WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis
- Sonoda, K.H., Yoshimura, T., Takeda, A., Ishibashi, T., Hamano, S. and Yoshida, H. (2007) ‘WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis’, International Immunology, 19(1), pp. 93–98.
https://doi.org/10.1093/intimm/dxl125 - Commentary: In an animal model of uveitis, we showed that WSX-1, the receptor for the immunoregulatory substance IL-27, plays an essential role in the very first stage (initiation) of the disease. This finding is important for understanding how uveitis develops and suggests the possibility of developing treatments that target the early stage of the disease.
- Collaborative study with Drs. Sonoda and Yoshida.
- Sonoda, K.H., Yoshimura, T., Takeda, A., Ishibashi, T., Hamano, S. and Yoshida, H. (2007) ‘WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis’, International Immunology, 19(1), pp. 93–98.
- Suppression of Autoimmune Retinal Inflammation by an Antiangiogenic Drug
- Yoshimura, T., Benny, O., Bazinet, L. and D’Amato, R.J. (2013) ‘Suppression of autoimmune retinal inflammation by an antiangiogenic drug’, PLoS One, 8(6), p. e66219.
https://pubmed.ncbi.nlm.nih.gov/23785488/ - Commentary: We showed that a drug originally developed to stop abnormal blood vessel growth can also strongly suppress the immune cells that cause autoimmune uveitis. This finding highlights how closely blood vessel formation and inflammation are linked in eye diseases.
- First Author: I demonstrated that a drug originally developed to stop abnormal blood vessel growth can also potently suppress the immune cells that cause autoimmune uveitis. This finding highlights the close relationship between blood vessel formation and inflammation in eye diseases.
- Yoshimura, T., Benny, O., Bazinet, L. and D’Amato, R.J. (2013) ‘Suppression of autoimmune retinal inflammation by an antiangiogenic drug’, PLoS One, 8(6), p. e66219.
- Crucial role of P2X7 receptor for effector T cell activation in experimental autoimmune uveitis
https://link.springer.com/article/10.1007/s10384-018-0587-4- Takeda, A., Yamada, H., Hasegawa, E., Arima, M., Notomi, S., Myojin, S., Yoshimura, T., Hisatomi, T., Enaida, H., Yanai, R., Kimura, K., Ishibashi, T. and Sonoda, K.H. (2018) ‘Crucial role of P2X7 receptor for effector T cell activation in experimental autoimmune uveitis’, Japanese Journal of Ophthalmology, 62(3), pp. 398–406.
- Commentary: We found that the “P2X7 receptor” on the surface of immune cells that cause eye inflammation is extremely important for activating the inflammatory response. We showed that blocking this receptor with a drug greatly suppresses inflammation, opening the way to the development of new treatments for uveitis.
- Collaborative study with Drs. Takeda and Sonoda.
- Dietary Omega-3 Fatty Acids Suppress Experimental Autoimmune Uveitis in Association with Inhibition of Th1 and Th17 Cell Function
- Shoda, H., Yanai, R., Yoshimura, T., Nagai, T., Kimura, K., Sobrin, L., Connor, K.M., Sakoda, Y., Tamada, K., Ikeda, T. and Sonoda, K.H. (2015) ‘Dietary omega-3 fatty acids suppress experimental autoimmune uveitis in association with inhibition of Th1 and Th17 cell function’, PLoS One, 10(9), p. e0138241.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138241 - Commentary: We showed that taking omega-3 fatty acids, abundant in fish oil and other sources, through the diet helps relieve eye inflammation. Omega-3 fatty acids suppress autoimmune uveitis by dampening the activity of specific immune cells that attack the retina.
- Collaborative study with Drs. Shoda, Yanai, and Sonoda.
- Shoda, H., Yanai, R., Yoshimura, T., Nagai, T., Kimura, K., Sobrin, L., Connor, K.M., Sakoda, Y., Tamada, K., Ikeda, T. and Sonoda, K.H. (2015) ‘Dietary omega-3 fatty acids suppress experimental autoimmune uveitis in association with inhibition of Th1 and Th17 cell function’, PLoS One, 10(9), p. e0138241.
- Aminoimidazole Carboxamide Ribonucleotide Ameliorates Experimental Autoimmune Uveitis
- Suzuki, J., Yoshimura, T., Simeonova, M., Tsuruma, K., Hisatomi, T., Ishibashi, T., Sheik-Ali, S. and Vavvas, D.G. (2012) ‘Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitis’, Investigative Ophthalmology & Visual Science, 53(7), pp. 3879–3887.
https://doi.org/10.1167/iovs.11-9323 - Commentary: We found that a drug called AICAR effectively suppresses inflammation in an animal model of uveitis. By weakening the “command center” of the immune cells that cause inflammation, this drug is expected to prevent attacks on the retina before they occur.
- Collaborative study with Drs. Suzuki and Vavvas.
- Suzuki, J., Yoshimura, T., Simeonova, M., Tsuruma, K., Hisatomi, T., Ishibashi, T., Sheik-Ali, S. and Vavvas, D.G. (2012) ‘Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitis’, Investigative Ophthalmology & Visual Science, 53(7), pp. 3879–3887.
- Differential roles for IFN-γ and IL-17 in experimental autoimmune uveoretinitis
- Yoshimura, T., Sonoda, K.H., Miyazaki, Y., Iwakura, Y., Ishibashi, T., Yoshimura, A. and Yoshida, H. (2008) ‘Differential roles for IFN-γ and IL-17 in experimental autoimmune uveoretinitis’, International Immunology, 20(2), pp. 209–214.
https://doi.org/10.1093/intimm/dxm135 - Commentary: There are several types of immune cells that cause uveitis. We investigated the role of “IL-17,” a substance produced by one of them, Th17 cells. We found that IL-17 is a factor that worsens disease not in the early stage but in the chronic phase, when inflammation persists.
- First Author: I investigated the role of “IL-17,” a substance produced by Th17 immune cells, in uveitis. The results showed that IL-17 is a key factor in worsening the disease not in the initial phase, but during the chronic phase where inflammation persists.
- Yoshimura, T., Sonoda, K.H., Miyazaki, Y., Iwakura, Y., Ishibashi, T., Yoshimura, A. and Yoshida, H. (2008) ‘Differential roles for IFN-γ and IL-17 in experimental autoimmune uveoretinitis’, International Immunology, 20(2), pp. 209–214.
Retinal Diseases such as Age-Related Macular Degeneration (AMD), and Angiogenesis
- IL-23-Independent Induction of IL-17 from γδT Cells and Innate Lymphoid Cells Promotes Experimental Intraocular Neovascularization
- Hasegawa, E., Sonoda, K.H., Shichita, T., Morita, R., Sekiya, T., Kimura, A., Oshima, Y., Takeda, A., Yoshimura, T., Yoshida, S., Ishibashi, T. and Yoshimura, A. (2013) ‘IL-23-independent induction of IL-17 from γδT cells and innate lymphoid cells promotes experimental intraocular neovascularization’, Journal of Immunology, 190(2), pp. 778–787.
https://doi.org/10.4049/jimmunol.1202495 - Commentary: We found that the inflammatory substance IL-17 is involved in the abnormal blood vessel growth that causes neovascular (wet) age-related macular degeneration. We determined that this substance is produced by the body’s early defense system (innate immunity), through a pathway different from what had been thought, and showed the possibility of a new treatment strategy.
- Collaborative study with Drs. Hasegawa, Sonoda, and Yoshimura.
- Hasegawa, E., Sonoda, K.H., Shichita, T., Morita, R., Sekiya, T., Kimura, A., Oshima, Y., Takeda, A., Yoshimura, T., Yoshida, S., Ishibashi, T. and Yoshimura, A. (2013) ‘IL-23-independent induction of IL-17 from γδT cells and innate lymphoid cells promotes experimental intraocular neovascularization’, Journal of Immunology, 190(2), pp. 778–787.
- Broad Spectrum Antiangiogenic Treatment for Ocular Neovascular Diseases
- Benny, O., Nakai, K., Yoshimura, T. and D’Amato, R.J. (2010) ‘Broad spectrum antiangiogenic treatment for ocular neovascular diseases’, PLoS One, 5(9), p. e12515.
https://doi.org/10.1371/journal.pone.0012515 - Commentary: We showed that a drug called Lodamin has very broad effects against abnormal blood vessel growth in the eye. The drug can simultaneously suppress the three main causes of disease progression (blood vessel growth, leakage of blood components, and inflammation), and it was also confirmed to shrink existing lesions.
- Collaborative study with Drs. Benny and D’Amato.
- Benny, O., Nakai, K., Yoshimura, T. and D’Amato, R.J. (2010) ‘Broad spectrum antiangiogenic treatment for ocular neovascular diseases’, PLoS One, 5(9), p. e12515.
- Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment
- Adini, I., Ghosh, K., Adini, A., Chi, Z.L., Yoshimura, T., Benny, O., Connor, K.M. and D’Amato, R.J. (2013) ‘Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment’, Journal of Clinical Investigation, 123(12), pp. 5273–5285.
https://www.jci.org/articles/view/69404 - Commentary: We found that melanocytes, the cells that produce skin pigment, secrete a blood vessel growth-promoting substance called fibromodulin. Cells with less pigment secrete more of it, which may be a key to explaining the link between skin color and susceptibility to vascular diseases such as neovascular age-related macular degeneration.
- Collaborative study with Drs. Adini and D’Amato.
- Adini, I., Ghosh, K., Adini, A., Chi, Z.L., Yoshimura, T., Benny, O., Connor, K.M. and D’Amato, R.J. (2013) ‘Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment’, Journal of Clinical Investigation, 123(12), pp. 5273–5285.
- M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy
- Zhou, Y., Yoshida, S., Nakao, S., Yoshimura, T., Miyaguni, D., Kobayashi, Y., Nakama, T., Yamaguchi, M., Ishikawa, K., Oshima, Y. and Ishibashi, T. (2015) ‘M2 macrophages enhance pathological neovascularization in the mouse model of oxygen-induced retinopathy’, Investigative Ophthalmology & Visual Science, 56(8), pp. 4786–4796.
https://doi.org/10.1167/iovs.14-16012 - Commentary: In retinal diseases caused by a disturbed oxygen balance, such as retinopathy of prematurity, we found that a specific immune cell, the M2 macrophage, actively promotes the growth of harmful, fragile blood vessels. Suppressing the activity of these cells may become a new treatment strategy to prevent blindness from these diseases.
- Collaborative study with Drs. Zhou and Yoshida.
- Zhou, Y., Yoshida, S., Nakao, S., Yoshimura, T., Miyaguni, D., Kobayashi, Y., Nakama, T., Yamaguchi, M., Ishikawa, K., Oshima, Y. and Ishibashi, T. (2015) ‘M2 macrophages enhance pathological neovascularization in the mouse model of oxygen-induced retinopathy’, Investigative Ophthalmology & Visual Science, 56(8), pp. 4786–4796.
- Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization
- Zhou, Y., Yoshida, S., Kubo, Y., Yoshimura, T., Kobayashi, Y., Nakama, T., Yamaguchi, M., Ishikawa, K., Oshima, Y. and Ishibashi, T. (2017) ‘Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization’, Molecular Medicine Reports, 15(6), pp. 3949–3956.
https://doi.org/10.3892/mmr.2017.6491 - Commentary: Around the abnormal blood vessels that cause neovascular (wet) age-related macular degeneration, we found two types of macrophages (M1 and M2), each located in a different place. In particular, the M1 type, which worsens inflammation, is found immediately next to the abnormal vessels, so developing treatments that target these cells is expected.
- Collaborative study with Drs. Zhou and Yoshida.
- Zhou, Y., Yoshida, S., Kubo, Y., Yoshimura, T., Kobayashi, Y., Nakama, T., Yamaguchi, M., Ishikawa, K., Oshima, Y. and Ishibashi, T. (2017) ‘Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization’, Molecular Medicine Reports, 15(6), pp. 3949–3956.
- Interleukin-18 regulates pathological intraocular neovascularization
- Qiao, H., Sonoda, K.H., Ikeda, Y., Yoshimura, T., Hijioka, K., Nakao, S., Hisatomi, T. and Ishibashi, T. (2007) ‘Interleukin-18 regulates pathological intraocular neovascularization’, Journal of Leukocyte Biology, 81(4), pp. 1012–1021.
https://doi.org/10.1189/jlb.0506342 - Commentary: We found that the cytokine interleukin-18 (IL-18) strongly promotes pathological angiogenesis in the eye. This research suggests that IL-18 could be a new therapeutic target for angiogenesis.
- Collaborative study with Drs. Qiao and Sonoda.
- Qiao, H., Sonoda, K.H., Ikeda, Y., Yoshimura, T., Hijioka, K., Nakao, S., Hisatomi, T. and Ishibashi, T. (2007) ‘Interleukin-18 regulates pathological intraocular neovascularization’, Journal of Leukocyte Biology, 81(4), pp. 1012–1021.
- Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion
- Kunikata, H., Shimura, M., Nakazawa, T., Sonoda, K.H., Yoshimura, T., Fukuhara, T. and Nakazawa, T. (2012) ‘Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion’, Acta Ophthalmologica, 90(2), pp. 162–167.
https://doi.org/10.1111/j.1755-3768.2010.01892.x - Commentary: In patients with macular edema due to branch retinal vein occlusion, we analyzed the aqueous humor before and after intraocular injection of triamcinolone acetonide, a steroid. We clarified at the molecular level how the treatment changes inflammatory substances such as cytokines and chemokines. This research became an important scientific basis for objectively evaluating the effect of steroid treatment for macular edema.
- Collaborative study with Drs. Kunikata and Nakazawa.
- Kunikata, H., Shimura, M., Nakazawa, T., Sonoda, K.H., Yoshimura, T., Fukuhara, T. and Nakazawa, T. (2012) ‘Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion’, Acta Ophthalmologica, 90(2), pp. 162–167.
- IL-10 Is Significantly Involved in HSP70-Regulation of Experimental Subretinal Fibrosis.
- Yang, Y., Takeda, A., Yoshimura, T., Oshima, Y., Sonoda, K.H., and Ishibashi, T. (2013) ‘IL-10 Is Significantly Involved in HSP70-Regulation of Experimental Subretinal Fibrosis’, PLoS One, 8(12), p. e80288.
https://doi.org/10.1371/journal.pone.0091197 - Commentary: For “fibrosis,” in which a mass of fibrous tissue forms under the retina in age-related macular degeneration, we discovered a natural defense mechanism of the body. The special protein HSP70 acts on immune cells and makes them produce large amounts of IL-10, a substance that suppresses inflammation, thereby holding back the progression of fibrosis. This finding is an important clue for developing new treatments to suppress fibrosis.
- Collaborative study with Drs. Yang and Takeda. I am the corresponding author.
- Yang, Y., Takeda, A., Yoshimura, T., Oshima, Y., Sonoda, K.H., and Ishibashi, T. (2013) ‘IL-10 Is Significantly Involved in HSP70-Regulation of Experimental Subretinal Fibrosis’, PLoS One, 8(12), p. e80288.
General Ophthalmic Pathology and Clinical Reports
- Gene Expression Analysis of the Irrigation Solution Samples Collected during Vitrectomy for Idiopathic Epiretinal Membrane
- Myojin, S., Yoshimura, T., Yoshida, S. and Sonoda, K.H. (2016) ‘Gene expression analysis of the irrigation solution samples collected during vitrectomy for idiopathic epiretinal membrane’, PLoS One, 11(10), p. e0164355.
https://doi.org/10.1371/journal.pone.0164355 - Commentary: When we analyzed the fluid used to wash the inside of the eye during surgery for epiretinal membrane (a membrane forming on the retinal surface), we found that genes involved in inflammation and wound-healing processes were active. This showed that the disease is not simply a membrane forming but a state in which an active disease process is under way inside the eye.
- Collaborative study with Drs. Myojin and Sonoda. I am the corresponding author.
- Myojin, S., Yoshimura, T., Yoshida, S. and Sonoda, K.H. (2016) ‘Gene expression analysis of the irrigation solution samples collected during vitrectomy for idiopathic epiretinal membrane’, PLoS One, 11(10), p. e0164355.
- A case report of malignant lymphoma receiving infliximab therapy with Behçet’s disease
- Fukuhara, T., Sonoda, K.H., Yoshikawa, H., Yoshimura, T., Oshima, Y. and Ishibashi, T. (2014) ‘A case report of malignant lymphoma receiving infliximab therapy with Behçet’s disease’, Nippon Ganka Gakkai Zasshi, 118(5), pp. 440–445.
https://pubmed.ncbi.nlm.nih.gov/25011243/ - Commentary: We reported a rare case in which malignant lymphoma developed during treatment with infliximab, a biologic used to treat severe ocular symptoms of Behçet’s disease. Although this treatment is very effective, we warned medical professionals that rare adverse effects must be watched carefully during long-term use.
- Collaborative study with Drs. Fukuhara and Sonoda.
- Fukuhara, T., Sonoda, K.H., Yoshikawa, H., Yoshimura, T., Oshima, Y. and Ishibashi, T. (2014) ‘A case report of malignant lymphoma receiving infliximab therapy with Behçet’s disease’, Nippon Ganka Gakkai Zasshi, 118(5), pp. 440–445.
- Involvement of Periostin in Regression of Hyaloidvascular System during Ocular Development
- Arima, M., Yoshida, S., Nakama, T., Ishikawa, K., Nakao, S., Yoshimura, T., Asato, R., Sassa, Y., Kita, T., Enaida, H., Oshima, Y., Matsuda, A., Kudo, A. and Ishibashi, T. (2012) ‘Involvement of periostin in regression of hyaloidvascular system during ocular development’, Investigative Ophthalmology & Visual Science, 53(10), pp. 6495–6503.
https://doi.org/10.1167/iovs.12-9684 - Commentary: We studied how the temporary blood vessels inside the eye of a fetus (hyaloid vessels) disappear normally by birth. In the process, we found that a protein called periostin acts like a “glue” that attracts to the vessels the immune cells that clear away unneeded vessels.
- Collaborative study with Drs. Arima and Yoshida.
- Arima, M., Yoshida, S., Nakama, T., Ishikawa, K., Nakao, S., Yoshimura, T., Asato, R., Sassa, Y., Kita, T., Enaida, H., Oshima, Y., Matsuda, A., Kudo, A. and Ishibashi, T. (2012) ‘Involvement of periostin in regression of hyaloidvascular system during ocular development’, Investigative Ophthalmology & Visual Science, 53(10), pp. 6495–6503.
- Simultaneous Analysis of Multiple Cytokines in the Vitreous of Patients with Sarcoid Uveitis
- Nagata, K., Maruyama, K., Uno, K., Shinomiya, K., Yoneda, K., Hamuro, J., Sugita, S., Yoshimura, T., Sonoda, K.H., Mochizuki, M. and Kinoshita, S. (2012) ‘Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis’, Investigative Ophthalmology & Visual Science, 53(7), pp. 3827–3833.
https://doi.org/10.1167/iovs.11-9244 - Commentary: We analyzed in detail the fluid inside the eyes of patients with uveitis associated with sarcoidosis, a systemic disease. We found that as many as 17 inflammatory substances were markedly increased, and found that the combination of these substances may be related to how far the disease has progressed.
- Collaborative study with Drs. Nagata and Maruyama.
- Nagata, K., Maruyama, K., Uno, K., Shinomiya, K., Yoneda, K., Hamuro, J., Sugita, S., Yoshimura, T., Sonoda, K.H., Mochizuki, M. and Kinoshita, S. (2012) ‘Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis’, Investigative Ophthalmology & Visual Science, 53(7), pp. 3827–3833.
Drug Development and New Treatments (Patents Granted)
- MetAP-2 inhibitor polymersomes for therapeutic administration
- Benny-Ratsaby, O., D’Amato, R. and Yoshimura, T. (2018) ‘MetAP-2 inhibitor polymersomes for therapeutic administration’, US Patent 9,782,489.
https://www.expertkg.com/patent/?patent_id=08790634 - Commentary: This patent concerns a new technology for effectively delivering a MetAP-2 inhibitor, a drug that strongly inhibits angiogenesis, into the eye. By encapsulating the drug in highly biocompatible nanoparticles (polymersomes), it aims for a sustained therapeutic effect while reducing side effects. This technology has the potential to improve the effectiveness of treatments for age-related macular degeneration and other diseases.
- Co-developed with Drs. Benny-Ratsaby and D’Amato. U.S. patent.
- Benny-Ratsaby, O., D’Amato, R. and Yoshimura, T. (2018) ‘MetAP-2 inhibitor polymersomes for therapeutic administration’, US Patent 9,782,489.
![Takeru Eye Clinic | Takatori Shopping Street, Sawara-ku, Fukuoka City [Nishijin Station / Fujisaki Station]](https://takeru-eye.com/wp-content/uploads/2022/10/takeru_logo_for-WP-header.png)